
Efavirenz 600 mg (Efavir 600) is an antiretroviral medicine used to treat HIV-1 infection in adults and eligible children. It is prescribed in combination with other HIV medicines as part of antiretroviral therapy (ART). Efavirenz helps reduce the amount of HIV in the body, strengthens the immune system, and lowers the risk of HIV-related complications. It does not cure HIV but helps control the infection effectively.
| Generic name | Efavirenz |
| Strength | 600 mg |
| Manufacturer | Cipla |
| Package size | 30 Tablets |
| Used for | HIV-1 infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It works by blocking the reverse transcriptase enzyme that HIV needs to make copies of itself. This prevents the virus from multiplying, reduces the viral load, and helps protect the immune system.
Dr. Dhruv Patel is a qualified medical practitioner with a clinical interest in HIV care and long-term antiretroviral therapy. He helps patients understand how antiretroviral medicines control HIV and why consistent treatment is essential for maintaining viral suppression.